Sg Americas Securities, LLC Sarepta Therapeutics, Inc. Transaction History
Sg Americas Securities, LLC
- $24.4 Billion
- Q4 2024
A detailed history of Sg Americas Securities, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 926 shares of SRPT stock, worth $68,616. This represents 0.0% of its overall portfolio holdings.
Number of Shares
926
Previous 7,193
87.13%
Holding current value
$68,616
Previous $898,000
87.42%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding SRPT
# of Institutions
535Shares Held
87.4MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$765 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$673 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$644 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$321 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$302 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $6.49B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...